In a cohort of 123 patients with resected NSCLC from the CHEMORES study dataset,20 the ACE2 transcriptomics profile identified two distinct groups with low and high expression in normal lung tissues (collected during curative-intent surgery, at a distance >2 cm from the tumor). The gene discussed is ACE2; the disease is non-small cell lung carcinoma.